Danaher Corporation | TalkMarkets

Latest Posts

10 Stocks For 2023

Article By: David Kass

Sunday, December 25, 2022 7:37 AM EDT

The outlook for U.S. stocks in 2023 is uncertain primarily as a result of the likely increase in interest rates by the Fed throughout the year in order to reduce core PCE inflation from its current 4.7% over the past 12 months to its target of 2%.

In this article: BRK-B, CVX, DHR, HSY, OXY, PEP, PGR, AAPL, ATVI, KHC

Read

Beware Spins From Danaher’s Well-Oiled M&A Machine

Article By: Lipper Alpha Insight

Wednesday, October 5, 2022 9:45 PM EDT

The $200 billion conglomerate runs acquisitions through its signature kaizen-based system, delivering improvements that churn out model returns for shareholders. When parts are spun back out, however, they run less smoothly.

In this article: DHR Also: GE, FTV, NVST, VNT

Read

This Medical Device Stock Has Room To Run

Article By: Schaeffers Research

Friday, September 3, 2021 1:44 AM EDT

Danaher Corporation is a global science and technology conglomerate. Recently, on Aug. 30, the company announced the completion of its acquisition of Aldevron, expanding its capabilities into the important field of genomic medicine.

In this article: DHR

Read

5 Picks As Inflation Is Transitory And Tapering Is Not In View

Article By: Zacks Investment Research

Friday, June 18, 2021 4:00 AM EDT

In its latest FOMC meeting, Fed acknowledged that the U.S. economy is suffering from inflationary pressure and a rate hike may come before than expected.

In this article: DHR, FDX, SHW, TGT, NVDA

Read